BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9211202)

  • 1. The case for mild hyperhomocysteinaemia as a risk factor.
    Boers GH
    J Inherit Metab Dis; 1997 Jun; 20(2):301-6. PubMed ID: 9211202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocystinuria: what about mild hyperhomocysteinaemia?
    van den Berg M; Boers GH
    Postgrad Med J; 1996 Sep; 72(851):513-8. PubMed ID: 8949585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate hyperhomocysteinaemia and vascular disease: evidence, relevance and the effect of treatment.
    Boers G
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S127-30. PubMed ID: 9587040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
    Wilcken DE
    J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants of hyperhomocysteinaemia: the roles of cystathionine beta-synthase and 5,10-methylenetetrahydrofolate reductase.
    Blom HJ
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S208-12. PubMed ID: 11216902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases.
    Oussalah A; Guéant JL; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2011 Nov; 34(10):1173-84. PubMed ID: 21967576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia.
    Møller J; Nielsen GM; Tvedegaard KC; Andersen NT; Jørgensen PE
    Scand J Clin Lab Invest; 2000 Oct; 60(6):491-9. PubMed ID: 11129065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteinaemia after methionine overload as a coronary artery disease risk factor: importance of age and homocysteine levels.
    Reis RP; Azinheira J; Reis HP; Bordalo A; Santos L; Adao M; Pina JE; Ferreira NC; Luis AS
    Coron Artery Dis; 1995 Nov; 6(11):851-6. PubMed ID: 8696529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine loading does not enhance the predictive value of homocysteine serum testing for all-cause mortality or major adverse cardiac events.
    Dunkelgrun M; Hoeks SE; Schouten O; Feringa HH; Welten GM; Vidakovic R; van Gestel YR; van Domburg RT; Goei D; de Jonge R; Lindemans J; Poldermans D
    Intern Med J; 2009 Jan; 39(1):13-8. PubMed ID: 18336539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients.
    Massy ZA; Chadefaux-Vekemans B; Chevalier A; Bader CA; Drüeke TB; Legendre C; Lacour B; Kamoun P; Kreis H
    Nephrol Dial Transplant; 1994; 9(8):1103-8. PubMed ID: 7800208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.
    Laraqui A; Allami A; Carrié A; Coiffard AS; Benkouka F; Benjouad A; Bendriss A; Kadiri N; Bennouar N; Benomar A; Guedira A; Raisonnier A; Fellati S; Srairi JE; Benomar M
    Acta Cardiol; 2006 Feb; 61(1):51-61. PubMed ID: 16485733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinaemia and vascular disease.
    Townend J; O'Sullivan J; Wilde JT
    Blood Rev; 1998 Mar; 12(1):23-34. PubMed ID: 9597195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.
    Lolin YI; Sanderson JE; Cheng SK; Chan CF; Pang CP; Woo KS; Masarei JR
    Heart; 1996 Aug; 76(2):117-22. PubMed ID: 8795472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels.
    Lievers KJ; Kluijtmans LA; Heil SG; Boers GH; Verhoef P; van Oppenraay-Emmerzaal D; den Heijer M; Trijbels FJ; Blom HJ
    Eur J Hum Genet; 2001 Aug; 9(8):583-9. PubMed ID: 11528503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
    den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Haak HL; Wijermans PW; Bos GM
    Lancet; 1995 Apr; 345(8954):882-5. PubMed ID: 7707810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinaemia and vitamin B12 deficiency: the long-term effects in cardiovascular disease.
    van Oijen MG; Vlemmix F; Laheij RJ; Paloheimo L; Jansen JB; Verheugt FW
    Cardiology; 2007; 107(1):57-62. PubMed ID: 16763373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of vascular function in hyperhomocysteinaemia: relationship to atherothrombotic disease.
    Stehouwer CD; Jakobs C
    Eur J Pediatr; 1998 Apr; 157 Suppl 2():S107-11. PubMed ID: 9587036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.